HLA-DQB1_NN
codon_NN
57_CD
is_VBZ
critical_JJ
for_IN
peptide_NN
binding_NN
and_CC
recognition_NN
._.

The_DT
association_NN
of_IN
specific_JJ
HLA-DQ_NN
alleles_NNS
with_IN
autoimmunity_NN
is_VBZ
correlated_VBN
with_IN
discrete_JJ
polymorphisms_NNS
in_IN
the_DT
HLA-DQ_NN
sequence_NN
that_WDT
are_VBP
localized_JJ
within_IN
sites_NNS
suitable_JJ
for_IN
peptide_NN
recognition_NN
._.

The_DT
polymorphism_NN
at_IN
residue_NN
57_CD
of_IN
the_DT
DQB1_NN
polypeptide_NN
is_VBZ
of_IN
particular_JJ
interest_NN
since_IN
it_PRP
may_MD
play_VB
a_DT
major_JJ
structural_JJ
role_NN
in_IN
the_DT
formation_NN
of_IN
a_DT
salt_NN
bridge_NN
structure_NN
at_IN
one_CD
end_NN
of_IN
the_DT
peptide-binding_JJ
cleft_NN
of_IN
the_DT
DQ_NN
molecules_NNS
._.

This_DT
polymorphism_NN
at_IN
residue_NN
57_CD
is_VBZ
a_DT
recurrent_JJ
feature_NN
of_IN
HLA-DQ_NN
evolution_NN
,_,
occurring_VBG
in_IN
multiple_JJ
distinct_JJ
allelic_JJ
families_NNS
,_,
which_WDT
implies_VBZ
a_DT
functional_JJ
selection_NN
for_IN
maintaining_VBG
variation_NN
at_IN
this_DT
position_NN
in_IN
the_DT
class_NN
II_CD
molecule_NN
._.

We_PRP
directly_RB
tested_VBD
the_DT
amino_NN
acid_NN
polymorphism_NN
at_IN
this_DT
site_NN
as_IN
a_DT
determinant_NN
for_IN
peptide_NN
binding_NN
and_CC
for_IN
antigen-specific_JJ
T_NN
cell_NN
stimulation_NN
._.

We_PRP
found_VBD
that_IN
a_DT
single_JJ
Ala_NN
--_:
&gt;_JJR
Asp_CD
amino_NN
acid_NN
57_CD
substitution_NN
in_IN
an_DT
HLA-DQ3_NN
.2_NN
molecule_NN
regulated_VBD
binding_NN
of_IN
an_DT
HSV-2_NN
VP-16-derived_JJ
peptide_NN
._.

A_DT
complementary_JJ
single-residue_NN
substitution_NN
in_IN
the_DT
peptide_NN
abolished_VBD
its_PRP$
binding_NN
to_TO
DQ3_NN
.2_NN
and_CC
converted_VBD
it_PRP
to_TO
a_DT
peptide_NN
that_WDT
can_MD
bind_VB
to_TO
DQ3_NN
.1_CD
and_CC
DQ3_NN
.3_NN
Asp-57-positive_JJ
MHC_NN
molecules_NNS
._.

These_DT
binding_VBG
studies_NNS
were_VBD
paralleled_VBN
by_IN
specific_JJ
T_NN
cell_NN
recognition_NN
of_IN
the_DT
class_NN
II-peptide_NN
complex_NN
,_,
in_IN
which_WDT
the_DT
substituted_VBN
peptide_NN
abolished_VBD
T_NN
cell_NN
reactivity_NN
,_,
which_WDT
was_VBD
directed_VBN
to_TO
the_DT
DQ3.2-peptide_NN
complex_NN
,_,
whereas_IN
the_DT
same_JJ
T_NN
cell_NN
clone_NN
recognized_VBD
the_DT
substituted_VBN
peptide_NN
presented_VBN
by_IN
DQ3_NN
.3_NN
,_,
a_DT
class_NN
II_CD
restriction_NN
element_NN
differing_VBG
from_IN
DQ3_NN
.2_NN
only_RB
at_IN
residue_NN
57_CD
._.

This_DT
structural_JJ
and_CC
functional_JJ
complementarity_NN
for_IN
residue_NN
57_CD
and_CC
a_DT
specific_JJ
peptide_NN
residue_NN
identifies_VBZ
this_DT
interaction_NN
as_IN
a_DT
key_JJ
controlling_VBG
determinant_NN
of_IN
restricted_JJ
recognition_NN
in_IN
HLA-DQ-specific_JJ
immune_JJ
response_NN
._.

